Antony Veale

1.2k total citations
24 papers, 696 citations indexed

About

Antony Veale is a scholar working on Pulmonary and Respiratory Medicine, Physiology and General Health Professions. According to data from OpenAlex, Antony Veale has authored 24 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 5 papers in General Health Professions. Recurrent topics in Antony Veale's work include Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers), Asthma and respiratory diseases (6 papers) and Smoking Behavior and Cessation (5 papers). Antony Veale is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers), Asthma and respiratory diseases (6 papers) and Smoking Behavior and Cessation (5 papers). Antony Veale collaborates with scholars based in Australia, United Kingdom and United States. Antony Veale's co-authors include Brian J Smith, Adrian Esterman, Kristin Carson‐Chahhoud, Malcolm P Brinn, Sarah Appleton, Matthew Peters, Christopher J Cates, Ben J. Smith, Eric Derom and Lawrence Korducki and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cochrane Database of Systematic Reviews.

In The Last Decade

Antony Veale

24 papers receiving 668 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antony Veale Australia 12 476 457 66 49 36 24 696
K. Annunziata United States 10 249 0.5× 361 0.8× 65 1.0× 70 1.4× 69 1.9× 29 679
Heather Sharpe Canada 11 206 0.4× 277 0.6× 112 1.7× 33 0.7× 44 1.2× 37 469
M. Barrueco Spain 15 172 0.4× 298 0.7× 171 2.6× 68 1.4× 38 1.1× 60 569
Vicky Kritikos Australia 18 385 0.8× 595 1.3× 160 2.4× 88 1.8× 18 0.5× 57 861
Lawrence H. Repsher United States 11 330 0.7× 362 0.8× 21 0.3× 60 1.2× 82 2.3× 20 589
Roxanne Rousseau Canada 12 343 0.7× 413 0.9× 59 0.9× 101 2.1× 30 0.8× 17 688
Lisette van den Bemt Netherlands 13 336 0.7× 290 0.6× 90 1.4× 35 0.7× 56 1.6× 35 538
Stuart Stoloff United States 16 751 1.6× 1.0k 2.3× 77 1.2× 36 0.7× 16 0.4× 45 1.2k
Ashraf Alzaabi United Arab Emirates 13 210 0.4× 206 0.5× 38 0.6× 46 0.9× 43 1.2× 29 434
Panagis Galiatsatos United States 12 87 0.2× 171 0.4× 75 1.1× 53 1.1× 64 1.8× 47 426

Countries citing papers authored by Antony Veale

Since Specialization
Citations

This map shows the geographic impact of Antony Veale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antony Veale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antony Veale more than expected).

Fields of papers citing papers by Antony Veale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antony Veale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antony Veale. The network helps show where Antony Veale may publish in the future.

Co-authorship network of co-authors of Antony Veale

This figure shows the co-authorship network connecting the top 25 collaborators of Antony Veale. A scholar is included among the top collaborators of Antony Veale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antony Veale. Antony Veale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
West, Alex, Nazia Chaudhuri, Adam Barczyk, et al.. (2023). Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose–response trial. Thorax. 78(9). 882–889. 35 indexed citations
2.
Heraganahally, Subash S., et al.. (2022). The Prevalence of Bronchodilator Responsiveness “Asthma” Among Adult Indigenous Australians Referred for Lung Function Testing in the Top End Northern Territory of Australia. Journal of Asthma and Allergy. Volume 15. 1305–1319. 15 indexed citations
3.
Carson‐Chahhoud, Kristin, Brian J Smith, Matthew Peters, et al.. (2020). Two-year efficacy of varenicline tartrate and counselling for inpatient smoking cessation (STOP study): A randomized controlled clinical trial. PLoS ONE. 15(4). e0231095–e0231095. 11 indexed citations
4.
5.
Buhl, Roland, François Maltais, R Abrahams, et al.. (2015). Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2–4). European Respiratory Journal. 45(4). 969–979. 245 indexed citations
6.
Buhl, Rikke, R Abrahams, Leif Bjermer, et al.. (2015). Safety of once-daily tiotropium and olodaterol fixed-dose combination via the Respimat in chronic obstructive pulmonary disease in two 1-year studies. Pneumologie. 69(S 01). 4 indexed citations
7.
Carson‐Chahhoud, Kristin, Bruce A. Smith, Malcolm P Brinn, et al.. (2014). Safety of Varenicline Tartrate and Counseling Versus Counseling Alone for Smoking Cessation: A Randomized Controlled Trial for Inpatients (STOP Study). Nicotine & Tobacco Research. 16(11). 1495–1502. 12 indexed citations
8.
Abrahams, R, Leif Bjermer, Eric Derom, et al.. (2014). P256 Safety Of Once-daily Tiotropium And Olodaterol Fixed-dose Combination Via The Respimat In Chronic Obstructive Pulmonary Disease In Two 1-year Studies. Thorax. 69(Suppl 2). A189–A190. 6 indexed citations
9.
Carson‐Chahhoud, Kristin, Brian J Smith, Malcolm P Brinn, et al.. (2014). Smoking cessation and tobacco prevention in Indigenous populations. SHILAP Revista de lepidopterología. 2014. 8 indexed citations
10.
11.
Carson‐Chahhoud, Kristin, Malcolm P Brinn, Matthew Peters, et al.. (2012). Interventions for smoking cessation in Indigenous populations. Cochrane Database of Systematic Reviews. 1. CD009046–CD009046. 82 indexed citations
12.
Smith, Brian J., Matthew Peters, Robert Fitridge, et al.. (2011). Varenicline Tartrate And Counselling Versus Counselling Alone In A Randomised Controlled Trial For Inpatient Smoking Cessation: 6 Month Interim Results. A5445–A5445. 5 indexed citations
13.
Appleton, Sarah, Phillippa Poole, Brian J Smith, et al.. (2006). Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews. 2013(1). CD001104–CD001104. 83 indexed citations
14.
Harris, Melanie, et al.. (2006). Providing patients with reviews of evidence about COPD treatments: a controlled trial of outcomes. Chronic Respiratory Disease. 3(3). 133–140. 12 indexed citations
15.
Harris, Melanie, Ben J. Smith, & Antony Veale. (2005). Printed patient education interventions to facilitate shared management of chronic disease: a literature review. Internal Medicine Journal. 35(12). 711–716. 23 indexed citations
16.
Smith, Bruce A., et al.. (2004). Eformoterol n-of-1 trials in chronic obstructive pulmonary disease poorly reversible to salbutamol. Chronic Respiratory Disease. 1(2). 63–69. 7 indexed citations
17.
Peat, JK & Antony Veale. (2001). Impact and aetiology of respiratory infections, asthma and airway disease in Australian Aborigines. Journal of Paediatrics and Child Health. 37(2). 108–112. 11 indexed citations
18.
Appleton, Sarah, et al.. (2001). Long-acting beta2-agonists for chronic obstructive pulmonary disease patients with poorly reversible airflow limitation. Cochrane Database of Systematic Reviews. CD001104–CD001104. 38 indexed citations
19.
Veale, Antony, Jennifer Peat, C. M. Salome, Ann J. Woolcock, & J. E. Thompson. (1997). ‘Normal’ lung function in rural Australian Aborigines*. Australian and New Zealand Journal of Medicine. 27(5). 543–549. 25 indexed citations
20.
Veale, Antony, Jennifer Peat, Euan R. Tovey, et al.. (1996). Asthma and atopy in four rural Australian Aboriginal communities. The Medical Journal of Australia. 165(4). 192–196. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. Annunziata Breakdown of academic impact, for papers by Heather Sharpe Breakdown of academic impact, for papers by M. Barrueco Breakdown of academic impact, for papers by Vicky Kritikos Breakdown of academic impact, for papers by Lawrence H. Repsher Breakdown of academic impact, for papers by Roxanne Rousseau Breakdown of academic impact, for papers by Lisette van den Bemt Breakdown of academic impact, for papers by Stuart Stoloff Breakdown of academic impact, for papers by Ashraf Alzaabi Breakdown of academic impact, for papers by Panagis Galiatsatos
Rankless by CCL
2026